Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Phase 2 Completed 49 enrolled Otsuka Pharmaceutical Development & Commercialization, Inc.

NaSingle-groupOpen-labelTreatment

Summary

This study will assess the helpfulness of the integrated call center in optimizing use of the Digital Medicine System in adult subjects with Schizophrenia, Major Depressive Disorder, or Bipolar Disorder taking oral aripiprazole.

Timeline

Start: 2016-03
Primary completion: 2016-09
Completion: 2016-09

Publications

Jan M, Coppin-Renz A, West R, Gallo CL, Cochran JM, Heumen EV, Fahmy M, Reuteman-Fowler JC. Safety Evaluation in Iterative Development of Wearable Patches for Aripiprazole Tablets With Sensor: Pooled Analysis of Clinical Trials. JMIR Form Res. 2023 Dec 12;7:e44768. doi: 10.2196/44768.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Aripiprazole	Other / unclassified	2 mg	Oral
Subject	Aripiprazole	Other / unclassified	5 mg	Oral
Subject	Aripiprazole	Other / unclassified	10 mg	Oral
Subject	Aripiprazole	Other / unclassified	15 mg	Oral
Subject	Aripiprazole	Other / unclassified	20 mg	Oral
Subject	Aripiprazole	Other / unclassified	30 mg	Oral

Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System

Summary

Timeline

Publications

Drugs

Indications